Alzeca Biosciences
PrivateLast Round
Series A
Aug 17, 2017
Total Funding Raised
$14.21M
Company Overview
Alzeca Biosciences is a biotechnology company that develops targeted MRI imaging agents for the early diagnosis of Alzheimer's disease and other neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alzeca Biosciences Comparables
Compare Alzeca Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InLighta BioSciences | 77% | |
| Aprinoia Therapeutics | 72% | |
| Reveal Pharmaceuticals | 71% |
Alzeca Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 17, 2017 | ||||
| Grant | Mar 9, 2016 |
Alzeca Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Series A |
| Fieldstone Partners | Series A, Seed |
| Cure Alzheimer's Fund | Seed |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 142% MoM.
- Aug 17, 2017
$11M round with Dolby Family Ventures and Fieldstone Partners.
Alzeca Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alzeca Biosciences's valuation, stock price, and market status.
Is Alzeca Biosciences a public or private company?
Alzeca Biosciences is a private company.
What is the current stock price of Alzeca Biosciences?
Alzeca Biosciences is a private company with no public stock price. Caplight tracks Alzeca Biosciences's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Alzeca Biosciences worth (valuation)?
Valuation information for Alzeca Biosciences is not publicly available.
Can I buy Alzeca Biosciences stock?
Alzeca Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alzeca Biosciences's last funding round?
Alzeca Biosciences's most recent funding round was Series A on August 17, 2017.
Who are the main investors in Alzeca Biosciences?
Key investors in Alzeca Biosciences include Dolby Family Ventures, Fieldstone Partners, Cure Alzheimer's Fund, Alzheimer's Drug Discovery Foundation.
Will Alzeca Biosciences IPO soon?
No public IPO plans have been announced for Alzeca Biosciences.
How can I track Alzeca Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alzeca Biosciences's secondary market activity and sign up for updates.